| [Commentary] The regulation of clinical stem cell research and applications: three dynamics of global regulatory diversification A Rosemann University of Sussex, 0 | | |
| A method for the ethical analysis of brain-inspired AI M Farisco, G Baldassarre, E Cartoni, A Leach, MA Petrovici, A Rosemann, ... Artificial Intelligence Review 57 (6), 1-27, 2024 | 4 | 2024 |
| Alter-standardizing clinical trials: the gold standard in the crossfire A Rosemann Science as Culture 28 (2), 125-148, 2019 | 20 | 2019 |
| Attitudes towards the donation of human embryos for stem cell research among Chinese IVF patients and students A Rosemann, H Luo Journal of Bioethical Inquiry 15 (3), 441-457, 2018 | 15 | 2018 |
| Balancing social justice and risk management in the governance of gene drive technology: Lessons from stem cell research A Rosemann The Matrix of Stem Cell Research, 187-206, 2019 | | 2019 |
| Challenge-driven innovation and responsible innovation: dynamics and disconnects explored through the UK’s industrial biotechnology sector A Rosemann, S Molyneux-Hodgson Journal of Responsible Innovation 10 (1), 2286762, 2023 | | 2023 |
| Clinical stem cell research collaborations between China and the USA: opportunities, challenges, possible solutions A Rosemann University of Sussex, 0 | | |
| Comparing national home-keeping and the regulation of translational stem cell applications: an international perspective M Sleeboom-Faulkner, CK Chekar, A Faulkner, C Heitmeyer, M Marouda, ... Social Science & Medicine 153, 240-249, 2016 | 43 | 2016 |
| Construção das terapias com células-tronco na Argentina: regulação, gestão de riscos e políticas de inovação G Bortz, A Rosemann, F Vasen Sociologias 21, 116-155, 2019 | 5 | 2019 |
| Contested tissues: the donation of oocytes and embryos in the IVF-stem cell interface in China A Rosemann Safety, Ethics and Regulations, 291-300, 2017 | | 2017 |
| Contextualizing experimental stem cell applications in China A Rosemann University of Sussex, 0 | | |
| Country report: Stem cell research in China A Rosemann, X Zhang, S Sui, Y Su, A Ely Centre for Bionetworking, 2013 | | 2013 |
| Developing capabilities for responsible research and innovation (RRI) G Ogoh, S Akintoye, D Eke, M Farisco, J Fernow, K Grasenick, M Guerrero, ... Journal of Responsible Technology 15, 100065, 2023 | | 2023 |
| Entre oportunidad y riesgo: regulación, expectativas y políticas CTI para células madre en Argentina G Bortz, F Vasen, A Rosemann Ciencia, docencia y tecnología, 38-74, 2017 | 5 | 2017 |
| Ethical strategies in stem cell banking: UK and Taiwan in cross-national perspective A Rosemann ISBC, 2011 | | 2011 |
| Ethnography of biomedicine collaborations: bioethics, clinical trails, malaria science and IVF, 2007-2010 M Strathern, R Simpson, S Salla, M Sleeboom-Faulkner, SY Hwang, ... UK Data Archive, 0 | | |
| Exploring the social, ethical, legal, and responsibility dimensions of artificial intelligence for health-a new column in Intelligent Medicine A Rosemann, X Zhang Intelligent Medicine 2 (02), 103-109, 2022 | 22 | 2022 |
| From Responsible Research and Innovation to responsibility by design BC Stahl, S Akintoye, L Bitsch, B Bringedal, D Eke, M Farisco, ... Journal of Responsible Innovation 8 (2), 175-198, 2021 | 67 | 2021 |
| Global diversification in medicine regulation: insights from regenerative stem cell medicine A Rosemann, F Vasen, G Bortz Science as Culture 28 (2), 223-249, 2019 | 15 | 2019 |
| Global regulatory developments for clinical stem cell research: diversification and challenges to collaborations A Rosemann, G Bortz, F Vasen, M Sleeboom-Faulkner Regenerative medicine 11 (7), 647-657, 2016 | 39 | 2016 |
